We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$1.02B
AUM Growth
-$36.2M
Cap. Flow
-$10.4M
Cap. Flow %
-1.02%
Top 10 Hldgs %
30.52%
Holding
491
New
188
Increased
28
Reduced
45
Closed
152

Top Buys

Rank Stock Value
1
ALLK
Allakos
ALLK
+$37.2M
2
CMPS
Compass Pathways
CMPS
+$14.9M
3
SVFA
SVF Investment Corp. Class A Ordinary Shares
SVFA
+$14.6M
4
CCVI
Churchill Capital Corp VI
CCVI
+$10.6M
5
HOOD icon
Robinhood
HOOD
+$9.23M

Top Sells

Rank Stock Value
1
HOV icon
Hovnanian Enterprises
HOV
+$16.7M
2
AUR icon
Aurora
AUR
+$16.4M
3
VHAQ
Viveon Health Acquisition Corp.
VHAQ
+$13.3M
4
SPAQ.WS
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
+$8.6M
5
CIFRW
Cipher Mining Warrant
CIFRW
+$8.36M

Sector Composition

Rank Sector Weight
1 Financials 38.91%
2 Healthcare 5.15%
3 Real Estate 4.9%
4 Consumer Discretionary 4.78%
5 Communication Services 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRM
251
DELISTED
Iterum Therapeutics
ITRM
$447K 0.04%
+76,016
New +$587K
CALA
252
DELISTED
Calithera Biosciences, Inc
CALA
$427K 0.04%
+32,063
New +$806K
ASMB icon
253
Assembly Biosciences
ASMB
$507M
$418K 0.04%
+14,933
New +$490K
CRDF icon
254
Cardiff Oncology
CRDF
$63.6M
$417K 0.04%
+69,381
New +$414K
OABI icon
255
OmniAb
OABI
$286M
$400K 0.04%
+40,000
New +$399K
ELOX
256
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$391K 0.04%
+13,841
New +$603K
PROF
257
Profound Medical
PROF
$263M
$388K 0.04%
+34,406
New +$430K
BCEL
258
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$376K 0.04%
+124,161
New +$580K
TRAW icon
259
Traws Pharma
TRAW
$7.81M
$370K 0.04%
+5,812
New +$467K
CIIGW
260
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$370K 0.04%
+37,500
New +$30.3K
HCNEW
261
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$368K 0.04%
+37,500
New +$43K
GRVY
262
GRAVITY
GRVY
$431M
$356K 0.03%
+5,232
New +$454K
MNOV icon
263
MediciNova
MNOV
$65.5M
$352K 0.03%
+131,495
New +$439K
BLUE
264
DELISTED
bluebird bio
BLUE
$350K 0.03%
+1,752
New +$413K
GTPBW
265
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$350K 0.03%
35,390
– –
ILLM
266
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$342K 0.03%
+90,478
New +$427K
SHQAW
267
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$341K 0.03%
+35,000
New +$19.6K
ARCKW
268
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$332K 0.03%
+33,333
New +$17.4K
EMKR
269
DELISTED
Emcore Corp
EMKR
$311K 0.03%
+4,461
New +$329K
TNXP icon
270
Tonix Pharmaceuticals
TNXP
$158M
$309K 0.03%
+1
New +$318K
CRON
271
Cronos Group
CRON
$1.06B
$295K 0.03%
+74,973
New +$375K
RVP icon
272
Retractable Technologies
RVP
$20.1M
$294K 0.03%
+42,397
New +$366K
FBRX icon
273
Forte Biosciences
FBRX
$1.57B
$292K 0.03%
+5,463
New +$367K
VVOS icon
274
Vivos Therapeutics
VVOS
$5.84M
$275K 0.03%
+4,892
New +$394K
VNET
275
VNET Group
VNET
$1.92B
$271K 0.03%
30,000
-65,000
-68% -$883K
9 10
11
12 13

Similar funds

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return

Anson Funds Management's Q4 2021 Portfolio in Review

As of Q4 2021, Anson Funds Management held 491 positions worth $1.02B, down 3.4% from $1.06B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Anson Funds Management's Q4 2021 filing shows 188 new, 28 increased, 45 reduced and 152 closed positions. Its largest new stake was Allakos: 454,496 shares worth $4.45M. The largest sale was Hovnanian Enterprises, an estimated $16.7M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Real Estate.

  • Anson Funds Management's largest Q4 2021 buy was Allakos: 454,496 shares worth $4.45M.
  • Anson Funds Management added most to Compass Pathways in Q4 2021, an estimated $14.9M increase.
  • Anson Funds Management's biggest Q4 2021 reduction was Hovnanian Enterprises, cutting an estimated $16.7M.
  • Anson Funds Management fully exited Aurora in Q4 2021, selling an estimated $16.4M.
  • Anson Funds Management's ten largest holdings make up 31% of its $1.02B portfolio in Q4 2021.
  • Anson Funds Management opened 188 new positions and closed 152 in Q4 2021.
  • Anson Funds Management's portfolio value fell 3.4% quarter-over-quarter to $1.02B.

Based on Anson Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.